Abstract:Objective To investigate the expression of microRNA-155/fork-head box protein O 3a (microRNA-155/FOXO 3a) axis in atrial tissue of patients with atrial fibrillation after cardiac surgery and its relationship with atrial fibrosis. Methods Ninety two patients with rheumatic valvular heart disease who underwent cardiac surgery in Qinghai Provincial Cardiovascular and Cerebrovascular Disease Hospital from February 2018 to April 2019 were selected and divided into atrial fibrillation group (43 cases) and sinus rhythm group (49 cases) according to their medical history, electrocardiogram (ECG) and 24-hour dynamic electrocardiogram (DCG). Right atrial tissue was collected during cardiac surgery, real-time quantitative polymerase chain reaction (RT-qPCR) was used to detect the expressions of microRNA-155 and FOXO3a in atrial tissue, the expression levels of FOXO3a and p-FOXO3a in atrial tissue were detected by immunoblotting (WB), the collagen volume fraction (CVF) of atrial tissue was calculated by Masson staining and computer imaging analysis system to evaluate the degree of atrial fibrosis, and Pearson method was used to analyze the correlations of microRNA-155, p-FOXO3a protein levels and CVF in atrial tissue. Results Compared with sinus rhythm group, the diameters of left atrium and right atrium increased significantly, the level of microRNA-155 and CVF in atrial tissue increased significantly, and the levels of FOXO3a mRNA and p-FOXO3a protein decreased significantly (all P < 0.05). The levels of microRNA-155 and p-FOXO3a protein in atrial tissue were negatively correlated (r = -0.485, P < 0.05), while the levels of microRNA-155 in atrial tissue were positively correlated with CVF (r = 0.490, P < 0.05), and the level of p-FOXO3a protein in atrial tissue was negatively correlated with CVF (r = -0.471, P < 0.05). Conclusions The high expression of microRNA-155 and low expression of p-FOXO3a protein in atrial tissue of patients with atrial fibrillation after cardiac surgery are both related to atrial fibrosis, which affect the occurrence and maintenance of atrial fibrillation jointly.